The road for Canadian legal cannabis operators has been littered with hardship since the industry took a header in 2019. Restrictive regulations, combined with bad business practices in a…
TLRY
The legal cannabis revolution was expected to create successful billion-dollar cultivators and retailers. After all the black market for weed was massive, why wouldn’t that convert over to the…
Tilray Brands (TLRY.T), a Canadian-based cannabis lifestyle and consumer goods company, reported it had a net loss of $434.13 million USD in Q4 2022 compared to a net income…
Is it time to buy Cannabis? Over the recent weeks, here on Equity Guru, I have been telling readers and discord members that the bottom may be in for…
It hasn’t been fun being invested in the Cannabis space recently. A lot of eyes have been on the US side of things. The catalyst being Federal deregulation. I…
What to say about Cannabis stocks. You give us some hope, and then pull the rug from under us. If you are a member of Equity Guru’s Free Trading…
Cannabis Stocks have been on a tear. WallStreetBets have been discussing Tilray (TLRY), Aphria (APHA) and Sundial (SNDL) to name a few. The fundamental case has been the US…
Tilray (TLRY.Q) is up 37% today after inking an importation and distribution agreement with Grow Pharma to get their medical cannabis products into the United Kingdom markets, according to…
You will grow through what you go through. It sounds like one of those motivational platitudes spouted at high speed on whatever social networking platform you choose to frequent,…
If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and…